ACTRN12617000045314招募中不适用
Selection of appropriate tranexamic acid dose to prevent fibrinolysis in pediatric cardiac surgery
king faisal specialized hospital and research centre0 个研究点目标入组 90 人开始时间: 2017年1月10日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 90
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- — 至 13 Years（—）
- 性别
- All
入选标准
- 未提供
排除标准
- 未提供
研究者
相似试验
已完成
4 期
Search for optimum dose and timing of tranexamic acid administration in cardiac surgery with cardiopulmonary bypass.cardiac insufficiency requiring surgery (for the patients undergoing cardiac surgery with cardiopulmonary bypass)JPRN-UMIN000003327Bellland General Hospital140
撤回
不适用
Optimal dose for topical use of tranexamic acid after cardiovascular surgeryDiseases of the circulatory systemKCT0004211Korea University Anam Hospital123
进行中（未招募）
1 期
Comparison of different dosing of Tranexamic Acid during major orthopedic surgery.EUCTR2018-003537-15-ATMedical University Vienna180
进行中（未招募）
1 期
External use of tranexamic acid to improve wound healingImmunomodulation of postoperative inflammatory reactions and therebyreduction of wound fluid production and improved healing by topicaladministration of tranexamic acid.MedDRA version: 20.0Level: LLTClassification code 10002784Term: AntifibrinolysisSystem Organ Class: 100000004865EUCTR2021-001381-38-DKPlastikkirurgisk og brystkirurgisk afdeling, Region Sjælland60
尚未招募
3 期
Role of tranexamic acid in reducing perioperative blood loss in abdominal oncosurgeries in group of patients aged between 25-75years.CTRI/2024/06/069240Indira Gandhi Medical College